Literature DB >> 12543292

Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis.

Manuel Macia1, Juan Avilés, Juan Navarro, Silvia Morales, Javier García.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12543292     DOI： 10.1016/s0002-9343(02)01354-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series.

Authors:  Luiz F Lisboa; Sonal Asthana; Andreas Kremer; Mark Swain; Sean M Bagshaw; Noel Gibney; Constantine J Karvellas
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

2.  Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus.

Authors:  Betti Schaefer; Franz Schaefer; Dieter Wittmer; Guido Engelmann; Daniel Wenning; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2011-11-15       Impact factor: 3.714

Review 3.  Artificial liver support in patients with liver failure: a modified DELPHI consensus of international experts.

Authors:  Faouzi Saliba; Rafael Bañares; Fin Stolze Larsen; Alexander Wilmer; Albert Parés; Steffen Mitzner; Jan Stange; Valentin Fuhrmann; Stefan Gilg; Tarek Hassanein; Didier Samuel; Josep Torner; Samir Jaber
Journal:  Intensive Care Med       Date:  2022-09-06       Impact factor: 41.787

Review 4.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Albumin liver dialysis as pregnancy-saving procedure in cholestatic liver disease and intractable pruritus.

Authors:  Maud Lemoine; Aurelie Revaux; Claire Francoz; Guillaume Ducarme; Sabine Brechignac; Emmanuel Jacquemin; Michele Uzan; Nathalie Ganne-Carrie
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.